One step closer to a universal flu vaccine? Penn In the News The New York Times One step closer to a universal flu vaccine? Scott Hensley of the Perelman School of Medicine and colleagues are developing a vaccine that could be used against the entire family of flu viruses, acting as a shield against potential pandemic threats. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Experimental flu shot aims to target 20 influenza viruses in a single vaccine Penn In the News USA Today Experimental flu shot aims to target 20 influenza viruses in a single vaccine Scott Hensley of the Perelman School of Medicine and colleagues hope that their new flu vaccine will provide some protection against all possible lineages of influenza. Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Universal vaccine to combat flu could be rolled out in the next couple of years Penn In the News Wales Online Universal vaccine to combat flu could be rolled out in the next couple of years Researchers at the Perelman School of Medicine have developed a universal flu vaccine that could be ready for use in just a few winters. Universal flu vaccine could counter future pandemic Penn In the News BBC News Universal flu vaccine could counter future pandemic Researchers at the Perelman School of Medicine have found a flu vaccine that could protect against any future pandemic strains, with a quote from Scott Hensley. Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Experimental flu shot aims to target 20 influenza viruses in a single vaccine Penn In the News USA Today Experimental flu shot aims to target 20 influenza viruses in a single vaccine Scott Hensley of the Perelman School of Medicine and colleagues hope that their new flu vaccine will provide some protection against all possible lineages of influenza. Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Universal vaccine to combat flu could be rolled out in the next couple of years Penn In the News Wales Online Universal vaccine to combat flu could be rolled out in the next couple of years Researchers at the Perelman School of Medicine have developed a universal flu vaccine that could be ready for use in just a few winters. Universal flu vaccine could counter future pandemic Penn In the News BBC News Universal flu vaccine could counter future pandemic Researchers at the Perelman School of Medicine have found a flu vaccine that could protect against any future pandemic strains, with a quote from Scott Hensley. Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Experimental flu shot aims to target 20 influenza viruses in a single vaccine Penn In the News USA Today Experimental flu shot aims to target 20 influenza viruses in a single vaccine Scott Hensley of the Perelman School of Medicine and colleagues hope that their new flu vaccine will provide some protection against all possible lineages of influenza. Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Universal vaccine to combat flu could be rolled out in the next couple of years Penn In the News Wales Online Universal vaccine to combat flu could be rolled out in the next couple of years Researchers at the Perelman School of Medicine have developed a universal flu vaccine that could be ready for use in just a few winters. Universal flu vaccine could counter future pandemic Penn In the News BBC News Universal flu vaccine could counter future pandemic Researchers at the Perelman School of Medicine have found a flu vaccine that could protect against any future pandemic strains, with a quote from Scott Hensley. Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Universal vaccine to combat flu could be rolled out in the next couple of years Penn In the News Wales Online Universal vaccine to combat flu could be rolled out in the next couple of years Researchers at the Perelman School of Medicine have developed a universal flu vaccine that could be ready for use in just a few winters. Universal flu vaccine could counter future pandemic Penn In the News BBC News Universal flu vaccine could counter future pandemic Researchers at the Perelman School of Medicine have found a flu vaccine that could protect against any future pandemic strains, with a quote from Scott Hensley. Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Universal vaccine to combat flu could be rolled out in the next couple of years Penn In the News Wales Online Universal vaccine to combat flu could be rolled out in the next couple of years Researchers at the Perelman School of Medicine have developed a universal flu vaccine that could be ready for use in just a few winters. Universal flu vaccine could counter future pandemic Penn In the News BBC News Universal flu vaccine could counter future pandemic Researchers at the Perelman School of Medicine have found a flu vaccine that could protect against any future pandemic strains, with a quote from Scott Hensley. Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Universal flu vaccine could counter future pandemic Penn In the News BBC News Universal flu vaccine could counter future pandemic Researchers at the Perelman School of Medicine have found a flu vaccine that could protect against any future pandemic strains, with a quote from Scott Hensley. Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Universal flu vaccine using RNA technology successfully tested in mice Penn In the News El Pais Universal flu vaccine using RNA technology successfully tested in mice Researchers from the Perelman School of Medicine are using messenger RNA technology to target all subtypes of influenza with a new vaccine candidate. Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Flu and colds are back with a vengeance—why now? Penn In the News Nature Flu and colds are back with a vengeance—why now? Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine. Load More
Monkeypox emergency orders are set to expire, but eradication isn’t likely Penn In the News NBC News Monkeypox emergency orders are set to expire, but eradication isn’t likely The increased rate of vaccinations means that recent U.S. monkeypox cases tend to be among immunocompromised people, according to Stuart Isaacs of the Perelman School of Medicine.